Search Results - "ANDRE, Amy K"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies by RYAN, Christopher W, VOGELZANG, Nicholas J, VOKES, Everett E, KINDLER, Hedy L, UNDEVIA, Samir D, HUMERICKHOUSE, Rod, ANDRE, Amy K, QIANG WANG, CARR, Robert A, RATAIN, Mark J

    Published in Clinical cancer research (01-07-2004)
    “…Purpose: Atrasentan is an orally bioavailable selective antagonist of the endothelin receptor ET A . Due to the potential activity of this agent against…”
    Get full text
    Journal Article
  2. 2

    The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar) by Carr, Robert A, André, Amy K, Chen, Ping, Grabowski, Brian A, Chang, Min S, Locke, Charles S, Williams, Laura A, Chojkier, Mario

    Published in Nephron. Clinical practice (01-01-2006)
    “…Paricalcitol is highly protein bound, extensively metabolized and eliminated primarily by hepatobiliary excretion. This study was designed to determine if…”
    Get more information
    Journal Article